Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Beta-cell Destruction Through the Study of EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

NCT03369821 is registered in ClinicalTrials.gov with University of Exeter as lead sponsor.

NCT NCT03369821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Beta-cell Destruction Through the Study of EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Lead sponsor
University of Exeter
Phase
Observational
Overall status
Recruiting
Start date
September 19, 2017
Completion date
November 30, 2028
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type1 diabetes mellitus